Riskpilot← Back to searchSign inGet full accessCeravik AB
ABActiveOrg 5590237979Lönnviksvägen 34Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20150 employees
Revenue 2025
SEK 0
EBITDA margin
—
-7% vs 2024
Equity ratio
76.4%
Financial strength
Net profit 2025
SEK -5K
-8% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -5K | -7% |
| Net profit | SEK -5K | -8% |
| Total assets | SEK 94K | -7% |
| Equity | SEK 72K | -6% |
| Employees | 0 | — |
Legal name
Ceravik AB
Org number
5590237979
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
24 augusti 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva forskning, utveckling, produktion, marknadsföring, försäljning och utbildning inom tandvård och ortopedi samt därmed förenlig verksamhet. Bolaget ska bedriva import och export av medicinsk utrustning och dentalmaterial.
Address
Lönnviksvägen 34
Email
wangliying18@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −11 | −8 | −5 | −5 | −5 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −11 | −8 | −5 | −5 | −5 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −11 | −8 | −5 | −4 | −5 |
| Tax | −0 | — | — | — | — |
| Net profit | −11 | −8 | −5 | −4 | −5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 115 | 107 | 102 | 101 | 94 |
| Equity | 94 | 86 | 81 | 77 | 72 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 21 | 21 | 21 | 24 | 22 |
| Total debt | 21 | 21 | 21 | 24 | 22 |
EBITDA margin
-489300.0%
This company
15.8%
Market median
-3096935% vs market
20212025
Equity ratio
76.4%
This company
38.2%
Market median
+100% vs market
20212025
Return on equity
-6.6%
This company
18.4%
Market median
-136% vs market
20212025
Net profit margin
-476100.0%
This company
8.1%
Market median
-5877878% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LW Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
JZ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ceravik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Liying Wang | Chief Executive Officer | 0 companies |
| James Zhijian Shen | Chief Executive Officer | 0 companies |
| Mimmi Yiyi Shen | Deputy Board Member | 0 companies |